Articles

How and when does an anticancer drug leave its binding site?

Tiwary, Pratyush; Mondal, Jagannath; Berne, Bruce J.

Obtaining atomistic resolution of drug unbinding from a protein is a much sought-after experimental and computational challenge. We report the unbinding dynamics of the anticancer drug dasatinib from c-Src kinase in full atomistic resolution using enhanced sampling molecular dynamics simulations. We obtain multiple unbinding trajectories and determine a residence time in agreement with experiments. We observe coupled protein-water movement through multiple metastable intermediates. The water molecules form a hydrogen bond bridge, elongating a specific, evolutionarily preserved salt bridge and enabling conformation changes essential to ligand unbinding. This water insertion in the salt bridge acts as a molecular switch that controls unbinding. Our findings provide a mechanistic rationale for why it might be difficult to engineer drugs targeting certain specific c-Src kinase conformations to have longer residence times.

Files

Also Published In

Title
Science Advances
DOI
https://doi.org/10.1126/sciadv.1700014

More About This Work

Academic Units
Chemistry
Published Here
January 16, 2018